Integer Holdings's biggest risks in the FY2024 10-K
- Concentrated customer base creates significant revenue dependency on top clients.
- Heavy reliance on debt financing and convertible notes impacts capital structure.
- International sales and operations expose the business to extensive regulatory and currency risks.
The risks most specific to Integer Holdings
- Operational Risks
We depend heavily on a limited number of customers, and if we lose any of them or they reduce their business with us, we would lose a substantial portion of our revenues
Our top three customers accounted for approximately 47% of our revenues in 2024, creating significant revenue risk if demand drops.
- Operational Risks
We rely on third-party suppliers for raw materials, key products and subcomponents. Unavailability of, or increased prices for, these materials, products or subcomponents could adversely affect our results of operations and financial condition
We rely on third-party suppliers for raw materials including platinum, gold, titanium, nitinol, and lithium.
- Financial and Indebtedness Risks
We have significant indebtedness that could adversely affect our operations, financial condition, and cash flows if we fail to meet certain financial covenants required by our debt agreements or if our access to capital markets is interrupted
We had $1.0 billion in debt outstanding at December 31, 2024, under our Senior Secured Credit Facilities and 2028 Convertible Notes.
- Financial and Indebtedness Risks
The conditional conversion feature of the 2028 Convertible Notes could adversely affect our financial condition and operating results
Holders of our 2028 Convertible Notes may convert their notes early, triggering conversion features and affecting our financial condition.
- Financial and Indebtedness Risks
Our international sales and operations are subject to a variety of market and financial risks and costs that could adversely affect our profitability and operating results
Sales outside the U.S. accounted for approximately 45% of our sales for 2024 across Europe, Asia, Mexico, and South America.
- Financial and Indebtedness Risks
We may never realize the full value of our intangible assets, which represent a significant portion of our total assets
We held $1.8 billion of goodwill and intangible assets representing 58% of total assets at December 31, 2024.
- Legal and Compliance Risks
The healthcare industry is highly regulated and subject to various political, economic and regulatory changes that could increase our compliance costs and force us to modify how we develop and price our products
Our product lines are subject to regulations including the European Medical Device Regulation.
All 36 risk factors
Headings as the filing states them, in filing order.
Operational Risks
- 01We depend heavily on a limited number of customers, and if we lose any of them or they reduce their business with us, we would lose a substantial portion of our revenues
- 02We are subject to pricing pressures from customers and contractual pricing constraints, which could harm our operating results and financial condition
- 03We rely on third-party suppliers for raw materials, key products and subcomponents. Unavailability of, or increased prices for, these materials, products or subcomponents could adversely affect our results of operations and financial condition
- 04Interruptions of our manufacturing operations could delay production and adversely affect our operations
- 05We may not be able to attract, train and retain a sufficient number of qualified associates to maintain and grow our business
- 06Quality problems with our products could result in warranty claims and additional costs, could harm our reputation and could erode our competitive advantage
- 07Our operations are subject to cyber-attacks and other information technology disruptions that could have a material adverse effect on our business, results of operations and financial condition
- 08Global climate change and related emphasis on environmental, social and governance (“ESG”) matters by various stakeholders could negatively affect our business or the price of our common stock
- 09We are dependent upon our senior management team and key technical personnel and the loss of any of them could significantly harm us
- 10Consolidation in the healthcare industry could result in greater competition and reduce our revenues and harm our business and our operating results
Strategic Risks
- 11If we are unable to successfully market our current or future products, our business will be harmed and our revenues and operating results will be adversely affected
- 12We may face intense competition that could harm our business, including competitors, in-sourcing and the possibility of dual sourcing; and we may be unable to compete successfully against new entrants and established companies with greater resources
- 13If we do not respond to changes in technology, our products may become obsolete or less competitive and we may experience a loss of customers and lower revenues
- 14We intend to develop new products and expand into new geographic and product markets, which may not be successful and could harm our operating results
- 15If we are not successful in making acquisitions to expand and develop our business, our operating results may suffer
- 16Successful integration and anticipated benefits of acquisitions cannot be assured and integration matters could divert attention of management away from operations
Financial and Indebtedness Risks
- 17Our operating results may fluctuate, which may make it difficult to forecast our future performance and may result in volatility in our common stock price
- 18We have significant indebtedness that could adversely affect our operations, financial condition, and cash flows if we fail to meet certain financial covenants required by our debt agreements or if our access to capital markets is interrupted
- 19Economic and credit market uncertainty could interrupt our access to capital markets, borrowings, or financial transactions to hedge certain risks, which could adversely affect our business prospects and financial condition
- 20The conditional conversion feature of the 2028 Convertible Notes could adversely affect our financial condition and operating results
- 21Certain provisions in the 2028 Convertible Notes and the indenture governing the 2028 Convertible Notes could delay or prevent an otherwise beneficial takeover or takeover attempt of us
- 22Transactions relating to our 2028 Convertible Notes may affect the market price of our common stock
- 23We are subject to counterparty risk with respect to the capped call transactions
- 24Our international sales and operations are subject to a variety of market and financial risks and costs that could adversely affect our profitability and operating results
- 25These risks are also present in connection with our entry into new geographic markets
- 26We may never realize the full value of our intangible assets, which represent a significant portion of our total assets
Legal and Compliance Risks
- 27Regulatory issues resulting from product complaints, recalls or regulatory audits could harm our ability to produce and supply products or bring new products to market
- 28If we become subject to product liability claims, our operating results and financial condition could suffer
- 29If we are unable to protect our intellectual property and proprietary rights, our business could be harmed
- 30We may be subject to intellectual property claims, which could be costly and time consuming and could divert our management’s attention from our business operations
- 31A failure to comply with customer-driven policies and standards and third-party certification requirements or standards could adversely affect our business and reputation
- 32Our failure to obtain licenses from third parties for new technologies or the loss of these licenses could impair our ability to design and manufacture new products and reduce our revenues
- 33Our business is subject to environmental regulations that could be costly to comply with
- 34Our international operations expose us to legal and regulatory risks, which could adversely affect our business
- 35The healthcare industry is highly regulated and subject to various political, economic and regulatory changes that could increase our compliance costs and force us to modify how we develop and price our products
- 36Our business is indirectly subject to healthcare industry cost containment measures that could result in reduced sales of our products
Other Integer Holdings 10-Ks
- FY2025 10-K risk factors41 risks5 new16 reworded
Top three customers represented 49% of 2025 revenue, increasing concentration exposure.
Filed Feb 23, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.